Experimental Models of Inflammatory Bowel Diseases

Slides:



Advertisements
Similar presentations
An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation Barrette Kathleen – Dreesen Erwin Asseman.
Advertisements

KRISTEN DOSTIE Alteration of Chemotaxis in the Gut of IBD Patients.
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells  Kai Fang, Aristea.
Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
Substance P Mediates Proinflammatory Cytokine Release From Mesenteric Adipocytes in Inflammatory Bowel Disease Patients  Aristea Sideri, Kyriaki Bakirtzi,
Proposed pathogenesis of inflammatory bowel disease and target sites for pharmacological intervention. Shown are the interactions among bacterial antigens.
Immunotherapy of hepatocellular carcinoma
Volume 17, Issue 5, Pages (November 2002)
Volume 31, Issue 3, Pages (September 2009)
Volume 380, Issue 9853, Pages (November 2012)
Acute Graft-versus-Host Disease: Novel Biological Insights
Immune Responses to the Microbiota at the Intestinal Mucosal Surface
Volume 136, Issue 2, Pages (February 2009)
Combining Biologics in Inflammatory Bowel Disease and Other Immune Mediated Inflammatory Disorders  Robert P. Hirten, Marietta Iacucci, Shailja Shah,
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Microbial Influences in Inflammatory Bowel Diseases
The Th17 immune response in renal inflammation
Gut Microbiota: Mining for Therapeutic Potential
Volume 136, Issue 7, Pages e4 (June 2009)
Volume 61, Issue 6, Pages (June 2002)
Roles for Chemokines in Liver Disease
Colorectal cancer vaccines: Principles, results, and perspectives
Gut–liver immunity Journal of Hepatology
Putting the work of B and T cells together
The Gastrointestinal Tract and AIDS Pathogenesis
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Volume 137, Issue 5, Pages e1 (November 2009)
INTERLEUKIN 10 (IL-10) CATEGORY: RECEPTORS & MOLECULES
Volume 132, Issue 3, Pages (March 2007)
Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights
Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
Warren Strober, Ivan J. Fuss  Gastroenterology 
Volume 128, Issue 5, Pages (May 2005)
Volume 21, Issue 4, Pages (October 2017)
The lymphoid liver: Considerations on pathways to autoimmune injury
Volume 132, Issue 5, Pages (May 2007)
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Mucosal Immunology of Food Allergy
Kara Gross Margolis, Charalabos Pothoulakis  Gastroenterology 
Obesity, Inflammation, and Insulin Resistance
Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
Celiac Disease: From Pathogenesis to Novel Therapies
Volume 145, Issue 2, Pages (August 2013)
John T. Chang, William J. Sandborn  Gastroenterology 
Immunobiology of Mucosal HIV Infection and the Basis for Development of a New Generation of Mucosal AIDS Vaccines  Igor M. Belyakov, Jay A. Berzofsky 
The Role of Retinoic Acid in Tolerance and Immunity
Natural Killer Cell Memory
Vaccinating Against Helicobacter pylori: Dissecting the Mechanism
Volume 135, Issue 5, Pages e5 (November 2008)
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology—Thirty Years of Progress but Still Much to Be Done 
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Inflammasomes in Intestinal Inflammation and Cancer
Adiponectin: an enlarging role in acute kidney injury
Volume 148, Issue 3, Pages (March 2015)
Volume 21, Issue 4, Pages (October 2017)
Homeostasis and Inflammation in the Intestine
Volume 141, Issue 1, Pages (July 2011)
From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory Cells
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Monocyte-Macrophages and T Cells in Atherosclerosis
Asthma and Allergic Inflammation
The Biology of Intestinal Immunoglobulin A Responses
Learning Tolerance while Fighting Ignorance
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Volume 31, Issue 3, Pages (September 2009)
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
Presentation transcript:

Experimental Models of Inflammatory Bowel Diseases Patricia Kiesler, Ivan J. Fuss, Warren Strober  Cellular and Molecular Gastroenterology and Hepatology  Volume 1, Issue 2, Pages 154-170 (March 2015) DOI: 10.1016/j.jcmgh.2015.01.006 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Mechanism of dextran sulfate sodium (DSS) colitis. DSS colitis is most essentially a colitis due to loss of epithelial barrier function and entry of luminal organisms or their products into the lamina propria. Such entry results in stimulation of innate and adaptive lymphoid elements and secretion of proinflammatory cytokines and chemokines. In addition, it results in the influx of cells with cytotoxic potential such as neutrophils and inflammatory macrophages. Cellular and Molecular Gastroenterology and Hepatology 2015 1, 154-170DOI: (10.1016/j.jcmgh.2015.01.006) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Mechanism of oxazolone colitis. Oxazolone colitis is driven by natural killer T (NKT) cells that originate in the cytokine milieu of epithelial cells subjected to damage by oxazolone as well as hematopoietic cells in the lamina propria. As shown in the figure, the NKT cells are activated by glycolipids presented to them in the context of CD1 and then mediate toxicity via their direct cytotoxic activity directed at target epithelial cells bearing glycolipid antigen. Alternatively, the NKT cells mediate tissue damage via their production of interleukin-13, a cytokine that has been shown to affect tight junction proteins and to thereby affect epithelial barrier function. Cellular and Molecular Gastroenterology and Hepatology 2015 1, 154-170DOI: (10.1016/j.jcmgh.2015.01.006) Copyright © 2015 The Authors Terms and Conditions

Figure 3 The cell transfer colitis model. Cell transfer colitis is initiated in lymphopenic (SCID or Rag−/−) mice that are the recipients of naïve CD45RBhigh T cells, a cell population that cannot be induced to generate regulatory T cells in a timely fashion to prevent the expansion of effector T cells that mediate inflammation. However, if the naïve T cells are transferred in the company of mature CD45RBlow T cells that already contain regulatory T cells, the latter prevent the development of inflammation. This model thus provides a way of isolating the function of effector cells and regulatory cells. Cellular and Molecular Gastroenterology and Hepatology 2015 1, 154-170DOI: (10.1016/j.jcmgh.2015.01.006) Copyright © 2015 The Authors Terms and Conditions

Figure 4 The five experimental models of inflammation discussed in the text are grouped here in relation to their varying inducing conditions. To the right of the individual mouse models are the major mucosal immune functions/therapies/diseases that are best addressed using these respective models. Cellular and Molecular Gastroenterology and Hepatology 2015 1, 154-170DOI: (10.1016/j.jcmgh.2015.01.006) Copyright © 2015 The Authors Terms and Conditions